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Objectives We conducted a systematic review and meta-analysis to determine the predictive value of findings of coronary
computed tomography angiography for incident cardiovascular events.
Background Initial studies indicate a prognostic value of the technique; however, the level of evidence as well as exact inde-
pendent risk estimates remain unclear.
Methods We searched PubMed, EMBASE, and the Cochrane Library through January 2010 for studies that followed up 100
subjects for 1 year and reported at 1 hazard ratio (HR) of interest. Risk estimates for the presence of significant
coronary stenosis (primary endpoint; 50% diameter stenosis), left main coronary artery stenosis, each coronary ste-
nosis, 3-vessel disease, any plaque, per coronary segment containing plaque, and noncalcified plaque were derived in ran-
dom effect regression analysis, and causes of heterogeneity were determined in meta-regression analysis.
Results We identified 11 eligible articles including 7,335 participants (age 59.1  2.6 years, 62.8% male) with suspected
coronary artery disease. The presence of 1 significant coronary stenosis (9 studies, 3,670 participants, and 252
outcome events [6.8%] with 62% revascularizations) was associated with an annualized event rate of 11.9% (6.4% in
studies excluding revascularization). The corresponding HR was 10.74 (98% confidence interval [CI]: 6.37 to 18.11)
and 6.15 (95% CI: 3.22 to 11.74) in studies excluding revascularization. Adjustment for coronary calcification did not
attenuate the prognostic significance (p 0.79). The estimated HRs for left main stenosis, presence of plaque, and each
coronary segment containing plaque were 6.64 (95% CI: 2.6 to 17.3), 4.51 (95% CI: 2.2 to 9.3), and 1.23 (95% CI: 1.17 to
1.29), respectively.
Conclusions Presence and extent of coronary artery disease on coronary computed tomography angiography are strong, inde-
pendent predictors of cardiovascular events despite heterogeneity in endpoints, categorization of computed to-
mography findings, and study population. (J Am Coll Cardiol 2011;57:2426–36) © 2011 by the American Col-
lege of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.12.043Computed tomography (CT) technology has progressed
rapidly, and state-of-the-art equipment quickly disseminates,
so that coronary computed tomography angiography (CTA)
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2010, accepted December 4, 2010.increasingly penetrates clinical practices. Coronary CTA has
been well validated as an accurate noninvasive modality to
detect coronary artery stenoses (1), but also detects the presence
and extent of nonobstructive coronary artery disease (CAD).
However, the lack of robust outcome data has limited the level
of supportive recommendations from clinical practice guide-
lines (2).
In addition to its potential diagnostic value in patients with
acute and chronic chest pain, growing evidence indicates that
the presence and severity of CAD as defined by coronary CTA
is also associated with the risk for future cardiac events.
However, evidence from available individual studies is limited
by the large uncertainty around their individual risks estimates,
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June 14, 2011:2426–36 Meta-Analysis: Predictive Value of Cardiac CTAmostly as a result of the limited number of outcomes but also
due to differences among the populations investigated and the
outcomes reported. Thus, the actual risk associated with
specific findings in coronary CTA remains largely unclear, but
it is necessary to appropriately design future outcome studies
including risk modification in prospective, randomized inter-
vention trials and consideration of the public health impact of
an increased use of noninvasive cardiac imaging using coronary
CTA. Therefore, we performed a systematic review of studies
that assessed the prognostic value of coronary CTA
findings on a combined cardiovascular endpoint and pooled
available evidence in a meta-analysis.
Methods
Study selection. We searched PubMed, EMBASE, and
the Cochrane library through January 2010 using medical
subject headings “cardiac/coronary CT” or “cardiac/
coronary computed tomography” or “cardiac/coronary CT
angiography” or “cardiac/coronary CTA” or “cardiac/
coronary MDCT,” in combination with the text words
“atherosclerosis complications” or “mortality” or “survival
analysis” or “outcome” or “death” or “prognosis/prognostic.”
In addition, we obtained expert opinions (S.A., K.N., U.H.,
and C.R.B.) whether any potentially relevant study was
missed. We limited our search to articles published in
English, German, French, or Italian, and to those con-
Figure 1 Literature Research and Selection Process
of Studies Included in Analysis
CT  computed tomography; CV  cardiovascular. Figure by Craig Skaggs.aducted on human adults over
the age of 18 years. Reference
lists of all retrieved original pa-
pers and of review articles were
hand-searched to identify fur-
ther relevant studies (Fig. 1).
Finally, we searched for multi-
ple publications of retrieved ar-
ticles to obtain the most complete
and up-to-date study results.
Inclus ion and exc lus ion
criteria. Pre-specified study in-
clusion criteria were cohort studies
(prospective or retrospective) of 100 subjects who were
ollowed up for 1 year. Studies that included subjects with
uspected or known CAD were eligible for inclusion in the
resent analysis. Per definition, we included studies using
16-slice CT and electron-beam CT given that both tech-
iques have been comparably used for CTA in the past.
Given the different clinical scenario and very limited
vailability of long-term data, we excluded studies involving
atients with acute presentation, such as acute chest pain.
ata abstraction and definitions. Among potentially eli-
ible studies, 12 were excluded from the analysis. Six studies
id not provide any hazard ratio (HR) of interest (merely
rovided raw data and described the occurrence of events on
case basis) (3,4), included 100 subjects (5), included a
uplicate publication with a different focus of the analysis
6,7), reported on costs (8), or exclusively reported on
oncalcified plaque (9).
Two independent investigators abstracted information on
ll variables listed in Table 1. Discrepancies between the 2
nvestigators were resolved by discussion and reexamination
f the corresponding studies with a senior investigator
S.A., C.R.B., and U.H.) or by contacting the authors of the
ndividual studies. To determine whether the predictive
alue of the cardiac CT findings on plaque and stenosis was
ndependent of coronary artery calcification (as measured in
ative examinations), we abstracted HR from the source
ata with and without adjustment for coronary artery
alcification separately.
Study quality indicators included the presence or absence of an
ndpoint committee, blinded CT results and outcome assessment,
xclusion of subjects after enrollment, and endpoint definition.
he total subject number was defined as the number of partici-
ants in whom the risk estimates were derived.
RISK ESTIMATES. To summarize the available evidence, we
bstracted the HR of the individual studies pertaining to
ach CT category of interest. To minimize the effect of
onfounding, we included the most extensively adjusted HR
with associated 95% confidence interval [CI] derived from
ultivariate regression analysis) from each original study, if
vailable. For studies that did not provide multivariate
Abbreviations
and Acronyms
CAD  coronary artery
disease
CI  confidence interval
CT  computed
tomography
CTA  computed
tomography angiography
HR  hazard ratio
MI  myocardial infarctiondjusted HRs for each predictor of interest, the univariate
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First Author, Year
(Ref. #) Region Sample Type N
Age
(yrs) Men
History of
CAD/Diabetes/BMI (kg/m2)
CT
Scanner
Excluded Subjects/
Segments
Pundziute, 2007 (11) Europe Suspected or known CAD 100 59.0 0.59 0.35/0.14/N.R. 16/64-slice 4 (arrhythmia)/
0.3% (stent, motion)
vessels 1.5 mm
Min, 2007 (13) United States Suspected CAD, asymptomatic
with multiple CVRF
1,127 61.7 0.43 0/0.17/N.R. 16-slice N.R./N.R.
Gaemperli, 2008 (20) Europe Suspected or known CAD 220 63.0 0.65 0.17/0.15/27 64-slice 3/0.02% (stent, motion)
Ostrom, 2008 (22) United States Suspected CAD 2,538 59.0 0.70 0/0.14/29.4 EBCT N.R.
Carrigan, 2009 (14) United States Suspected CAD 227 54.0 0.61 0/0.09/N.R. 64-slice N.R.
Gopal, 2009 (21) United States Suspected CAD,
intermediate risk
493 58.0 0.70 0/0.15/N.R. EBCT N.R.
Hadamitzky,
2009 (10)
Europe Suspected CAD 1,150 60.2 0.69 0/0.08/25.7 64-slice 45/segments 1.5 mm
Rubinshtein,
2009 (23)
Middle East Suspected CAD 545 58.0 0.68 0/0.14/N.R. 64-slice 0.015% (motion,
calcium, size)
Aldrovandi, 2009 (19) Europe Suspected CAD 187 62.5 0.64 0/0.11/0.21 obese 64-slice N.R.
van Werkhoven,
2009 (12)
Europe Suspected CAD 432 58.0 0.59 0/0.28/0.21 obese 64-slice 59 (24 uninterpretable,
35 lost to FU/N.R.
van Werkhoven,
2009 (24)*
Europe Suspected CAD 316 57.0 0.61 0/0.40/0.23 obese 64-slice 15 (motion, SNR)/0
CT Findings Studied
Follow-Up
(Months) Endpoint Events
AC/CV
Mortality
Nonfatal
MI UAP
PCI/
CABG
Multivariable
Adjustment
Pundziute,
2007 (11)
Presence of plaque
Obstructive CAD (50%)
LM obstructive CAD
Segment any plaque
Segment obstructive CAD
Segment MCAP, CAP, NCAP
13.0 Combined CV 26 0/1 3 3 24/7 Scanner type, age,
hyperlipidemia,
hypertension,
family history of
CAD, smoking
Min, 2007 (13) Obstructive CAD (50%)
Obstructive CAD (70%)
LM obstructive CAD
Segment any plaque
3-vessel obstructive disease
15.3 AC mortality 39 39/0 0 0 0/0 Age, hyperlipidemia,
family history of
CAD
Gaemperli,
2008 (20)
Obstructive CAD (50%)
LM obstructive CAD
Presence of plaque
Segment with any plaque
Segment with NCAP, CAP, MCAP
14.0 Combined CV 59 3/1 3 2 58/16 None
Ostrom, 2008 (22) Presence of plaque
1/2/3 vessel nonobstructive CAD
1/2/3 vessel obstructive CAD
78.0 AC mortality 86 86/0 0 0 0/0 Age, sex, CVRF (CAC)
Carrigan,
2009 (14)
Obstructive CAD (50%)
LM obstructive CAD (30%)
Segment plaque (0–10)
Segment NCAP, MCAP, CAP
27.6 Combined CV 18 0/1 3 0 14/7 Age, dyslipidemia,
statin use, aspirin
Gopal, 2009 (21) Obstructive CAD (50%) 40.0 Combined CV 21 0/0 21 0 0/0 Age, sex, CVRF (CAC)
Hadamitzky,
2009 (10)
Obstructive CAD (50%) 18.0† Combined CV
(revasc. 30 days)
21 0/0 1 5 15/0 None
Aldrovandi,
2009 (19)
Obstructive CAD (50%) 24.0 Combined CV 20 0/0 3 1 16/0 N.R.
Rubinshtein,
2009 (23)
Obstructive CAD (25%) 18.2 Combined CV
(revasc. 30 days)
53 0/13 18 0 38/0 Age, sex, CAC,
risk factors
van Werkhoven,
2009 (12)
Obstructive CAD (50%)
Segments with obstructive CAD
Presence of plaque
Segment of any plaque
Segment with MCAP, NCAP, CAP
22.3 Combined CV 13 5/0 3 5 0/0 Age, sex (CAC)
van Werkhoven,
2009 (24)*
Obstructive CAD (50%)
Presence of plaque
20.4† Combined CV 21 6/0 8 7 0/0 CVRF
*In 2009, the same lead author published in Heart (12) and the European Heart Journal (24). †Median provided.
AC  all cause; BMI  body mass index; CABG  coronary artery bypass graft; CAC  coronary artery calcification; CAD  coronary artery disease; CAP  coronary atherosclerotic plaque; CT  computedtomography; CV cardiovascular; CVRF cardiovascular risk factors; EBCT electron-beam computed tomography; LM left main; MCAPmixed atherosclerotic plaque; MImyocardial infarction; NCAP
non-calcified atherosclerotic plaque; N.R. not reported; PCI  percutaneous coronary intervention; revasc. revascularization; SNR  signal-to-noise-ratio; UAP  unstable angina pectoris.
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ated 95% CI).
EVENT RATES. To provide information on absolute risks,
we derived the number and type of events for the presence
and absence of CT findings from the original studies. All
events were annualized by using the provided average
follow-up time (median was used in 3 studies [10–12]) and
summarized by weighting by sample size.
ASSUMPTIONS. To harmonize the CT predictors of interest,
e made the following assumptions. We excluded the
redictor “severe” stenosis (defined as 70% luminal nar-
owing) as a too optimistic assumption from the analysis for
he primary predictor of interest in 1 study (13), according
o the lead author’s recommendation. Also, to derive the
ooled risk estimate for the presence of left main coronary
rtery stenosis, we included 1 study that reported the risk
ssociated with the presence of 30% luminal narrowing
14), and 1 study that reported a combined predictor
dditionally including the proximal left anterior descending
oronary artery (11). As 1 study reported on the risk
ssociated with the absence of any atherosclerotic plaque
13), the risk associated with any atherosclerotic plaque was
erived by the reciprocal.
ata analysis and statistical methods. The primary ob-
ective of this systematic review was to assess the relation-
hip between the coronary CTA finding of a significant
oronary stenosis (50% luminal narrowing) and a com-
ined cardiovascular endpoint. Secondary predictors of in-
erest included the presence of any atherosclerotic plaque,
resence of a significant left main stenosis, and the risk
ssociated with each coronary segment containing plaque
17-segment model of the American Heart Association) (15).
We used the metafor package in the statistical software
ackage R (version 2.10.0) to pool the natural logarithms
ln) of the HR, using a random effect model (restricted
aximum-likelihood estimator). Between-study heteroge-
eity was examined using the Q statistic and the I2 statistic
16). Publication bias was assessed using plots of study results
gainst precision of the study (funnel plots). Symmetry of the
unnel plots was tested using the methods suggested by Egger
t al. (17) and Begg and Mazumdar (18).
Given the detected high degree of heterogeneity of the risk
atios, we subsequently conducted meta-regression analysis to
xplore pre-defined sources of heterogeneity of our primary
redictor of interest. The following pre-specified variables were
nalyzed: average age, proportion of males, proportion of
ubjects with body mass index 30 kg/m2, history of CAD,
CT technology employed (64-slice vs. other), follow-up time
(average), type of endpoint (all-cause mortality vs. combined
endpoint), multivariate adjustment (yes/no), potential of model
overfitting (yes/no, defined by the presence of1 covariate for
to 10 outcome events in the multivariate models), and study
uality (score containing number of quality indicators). For all
hese pre-specified variables, subgroup analysis for the primary
redictor of interest was performed to further investigate effect wodification, and HRs were estimated for each subgroup
stratified by median). A p value0.1 was selected to indicate
bsence of significant heterogeneity of the estimates. For
besity, body mass index was converted to the prevalence of
besity (body mass index 30 kg/m2) by assuming normal
istribution.
To determine whether the predictive value was indepen-
ent of coronary artery calcification, we fitted a mixed
egression model for the occurrence of events and modeled
binary variable whether the study was adjusted for coro-
ary artery calcification or not, as a covariate. Again, the
ost adjusted estimated variable was included and statistical
ifference of the covariate was determined.
All analysis was performed using R (version 2.10.0), and
p value 0.05 was considered to indicate statistical
ignificance.
esults
e identified 11 studies that met the inclusion criteria and
rovided at least 1 risk ratio (Fig. 1) (10–14,19–24).
haracteristics of all selected studies are detailed in Table 1.
verall, we included a total of 7,335 subjects (average age
9.1  2.6 years, 62.8% male) with an average follow-up
anging between 14 and 78 months (median 20.4 months).
he majority of included studies had a single-center design
82%, 9 of 11) and were conducted in Europe or the United
tates (55% and 36%, respectively); only 1 study was from
he Middle East (23).
The study population consisted of patients referred for
uspected coronary artery disease (100%). Two studies (18%)
dditionally included subjects with known coronary artery
isease. There was substantial heterogeneity among the re-
orted CT findings (Table 1), and several studies did not
rovide all pre-specified parameters. The 64-slice CT technol-
gy was used in 7 studies (64%), 16-slice technology was used
n 2 studies (18%) (11,13), and 2 studies used electron-beam
T (18%) (21,22). The number of observed outcome events as
ell as type of event by study is detailed in Table 1.
oronary stenosis by coronary CT angiography. Among
he included publications, 9 studies analyzed a combined
ardiovascular endpoint and provided an HR for the presence
f significant coronary stenosis (10–12,14,19–21,23,24). They
ncluded a total of 3,670 participants who were followed up
o 27.6 months (average 21.9 months). Based on 252 (6.8%)
utcome events (6% all-cause, 6% cardiovascular mortality,
3% nonfatal MI, 4% unstable angina requiring hospital-
zation, and 62% revascularizations), the combined esti-
ated HR was 10.74 (95% CI: 6.37 to 18.11) (Table 2,
ig. 2), indicating an approximately 10-fold higher risk
mong subjects with any detectable coronary stenosis by
TA compared with subjects without coronary stenosis.
he annualized (and weighted by sample size) event rates
mong subjects with and without significant coronary ste-
osis (weighted prevalence 70.7% and 29.3%, respectively)
ere 11.9% and 1.1%, respectively (Table 3) with substan-
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Meta-Analysis: Predictive Value of Cardiac CTA June 14, 2011:2426–36tial variability being present (i.e., annualized event rate in
subjects with a significant coronary stenosis: 3.3% to
57.7%).
There was significant between-study heterogeneity (Q
statistic, p  0.001), and according to the I2 test, 71.8% of
he variability could be explained by between-study hetero-
eneity. The funnel plot revealed no statistical sign of
symmetry (z  1.34, p  0.18).
In meta-regression analysis (Table 4), the risk estimate
erived from studies that included revascularization in their
ndpoint was significantly higher than studies excluding
evascularization from their endpoint (p  0.03), indicating
substantial source of heterogeneity. After exclusion of
evascularization from the endpoint, the annualized total
vent rate was 6.4% (overall annualized event rate dropped
rom 5.0% to 1.7% for all studies vs. studies excluding
evascularization from the endpoint, respectively). Also,
verage age in the source population and study quality score
ere identified to be a significant source of heterogeneity
Figure 2 Forest Plot of Single Studies in Analysis for Risk Asso
“Adjusted” indicates whether multivariate adjustment was performed. Horizontal lines
and the size of the rectangle is proportional to the weight given to each study in the m
CI). The dashed vertical line represents the reference of no increased risk. In 2009,
computed tomography; HR  hazard ratio; neg  negative; pos  positive. Figure illu
Summary Estimates of Relative Risks Associated With SecondaryTable 2 Summary Estimates of Relative Risks Associated With
CT Angiography Finding nStudies nParticipants
Significant coronary stenosis 9 3,670
Left main coronary artery stenosis 4 1,674
Each significant coronary stenosis 4 1,879
3-vessel disease 2 3,665
Any atherosclerotic plaque 6 4,733
Each coronary segment containing plaque 5 2,106
Each coronary segment containing noncalcified plaque 4 979
Data are summarized hazard ratios (95% confidence intervals [CIs]). *As derived from meta-regre
CT  computed tomography; nParticipants  number of subjects included in analysis; nStudies p  0.02 and p  0.001, respectively). In contrast, there
as no significant source of heterogeneity associated with
he proportion of males, obesity, history of CAD, CT
echnology used (64-slice vs. other), follow-up time, and
otential overfitting of the models (Table 4).
ncremental value beyond calcium scoring. Three studies
ncluding 3,465 participants and 128 cardiovascular events
rovided analyses of the incremental value of coronary CTA
eyond coronary calcification through multivariate analysis
21,22,24). The association between the presence of signif-
cant coronary stenosis or any plaque and cardiovascular
vents remained highly significant after adjustment for
oronary calcium (HR: 11.24 vs. 10.42, p  0.79,
espectively).
econdary predictors. Combined risk estimates as well as
tudy characteristics for the secondary CT predictors of
nterest are detailed in Table 2 and Figures 3 and 4). The
stimated increased risk associated with each coronary
tenosis (maximum of 17) was 35% (HR: 1.35, 95% CI:
d With Significant Coronary Stenosis
ent 95% confidence intervals (CIs). The rectangles represent the point estimate,
alysis. The diamond represents the summary estimate (size of the diamond  95%
me lead author published in Heart (12) and the European Heart Journal (24). CT 
by Craig Skaggs.
ary CT Angiographic Findingsondary Coronary CT Angiographic Findings
nts Hazard Ratio* (95% CI) I2 p Value Z p Value
52 10.74 (6.4–18.1) 85% 0.001 1.34 0.18
42 6.64 (2.6–17.3) 71.9% 0.009 0.49 0.62
45 1.35 (1.1–1.7) 95.1% 0.001 0.41 0.52
25 2.50 (1.9-3.3) 0% 0.55 0.32 0.87
44 4.51 (2.2–9.3) 26.7% 0.33 0.96 0.32
63 1.23 (1.17–1.29) 7.6% 0.35 0.7 0.50
24 1.29 (1.2–1.4) 0% 0.13 0.27 0.91
nalysis.
of studies included in analysis.ciate
repres
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strationCoronSec
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to 17.3) (Fig. 3A) for the presence of left coronary artery
stenosis compared with subjects without left main coronary
artery stenosis. There was significant variability of the risk
estimate (I2  71.9% and 77.7%, respectively), which was
attributed to higher risk in studies including revasculariza-
tion in their endpoint (p  0.04 and p  0.05, respectively)
and a higher prevalence of history of CAD (both p  0.05).
The presence of 3-vessel disease was associated with a
2.5-fold risk compared with subjects without 3-vessel dis-
ease (HR: 2.50, 95% CI: 1.9 to 3.3) (Fig. 3C); no hetero-
geneity and no publication bias were detected (p 0.55 and
0.87, respectively).
On average, presence of any atherosclerotic plaque was
detected in the majority of subjects (weighted average
62.2%) with an event rate of 0.4% among subjects without
any plaque (Table 3). Subjects with any plaque detected by
CT were at a 4.5-fold risk for events compared with
subjects without plaque detected (HR: 4.51, 95% CI: 2.2 to
9.3) (Fig. 4A). Also, significant increased risk was associated
with each segment containing any detectable plaque (HR:
1.23, 95% CI: 1.17 to 1.29) (Fig. 4B), and noncalcified
plaque (HR: 1.29, 95% CI: 1.2 to 1.4) (Fig. 4C); no
heterogeneity or publication bias was detected.
Discussion
To our knowledge, this is the first study combining
CT Angiographic Finding of Any Significant Coronary Stenosisand Any Atherosclerotic Plaque, Number of Events (%), and AnnualTable 3 CT Angi graphic Finding of Any Sig ifican C ronary Sand Any Atherosclerotic Plaque, Number of Events (%)
First Author, Year (Ref. #) N
All Annualized
Event Rate
All
Excluding
Revasc.
Pre
Presence of significant coronary stenosis
Pundziute, 2007 (11) 100 24.0% 6.4% 3
Gaemperli, 2008 (20) 220 23.0% 3.5% 9
Carrigan, 2009 (14) 227 3.5% 0.7% 5
Gopal, 2009 (21) 493 1.2% 1.2% 9
Hadamitzky, 2009 (10) 1,150 1.2% 0.3% 34
Aldrovandi, 2009 (19) 187 5.4% 1.0% 3
Rubinshtein, 2009 (23) 545 6.4% 3.0% 21
van Werkhoven, 2009 (12) 316 2.2% 1.3% 8
van Werkhoven, 2009 (24) 432 2.9% 1.9% 10
Weighted average 5.0% 1.7% 2
Presence of any atherosclerotic plaque
Pundziute, 2007 (11) 100 24.0% 6.4% 8
Gaemperli, 2008 (20) 220 23.0% 3.5% 17
Ostrom, 2008 (22) 2,538 0.5% 0.02% 1,45
van Werkhoven, 2009 (12) 316 2.2% 1.3% 23
van Werkoven, 2009 (24)* 432 2.9% 1.9% 29
Weighted average 3.0% 0.08% 6
Prevalence of computed tomography (CT) angiographic finding of any significant coronary stenosi
and annualized event rates among all subjects (also excluding revascularization [Revasc.] as an end
finding) as derived from crude event numbers provided in the source publications. Averages of risk
according to CT finding category was not provided. *In 2009, the same lead author published in Havailable evidence on the predictive value of coronaryCTA in a comprehensive analysis of the associated risks
and identifying sources of heterogeneity of the existing
data. These data may be particularly relevant to homog-
enize reporting standards for cardiac CT, to determine
appropriate design of prospective randomized trials for
risk modification on the basis of cardiac CT findings, and
to estimate the potential impact of noninvasive CT
imaging on healthcare systems (25).
The results of this systematic review and meta-analysis
indicate that CT-based findings of coronary plaque and
stenosis are strong independent predictors of future cardio-
vascular events. Specifically, the presence of significant
coronary stenosis was associated with a 10-fold higher risk
for all cardiovascular events (cardiovascular death, nonfatal
MI, unstable angina requiring hospitalization, and revascu-
larization) and 6-fold risk for death, MI, and unstable
angina requiring hospitalization independent of coronary
artery calcification. Moreover, our results show that there is
a 4.5-fold risk associated with the presence of any CAD and
that each diseased coronary segment portraits a 23% higher risk
for adverse outcomes. We also demonstrated that choice of
endpoints, classification of CT findings, study quality, and
study population (age) introduced substantial heterogeneity
with respect to risk prediction among existing studies.
Our data show that the heterogeneity among studies can
be partially attributed to differences in the classification and
reporting of CT findings. In fact, there was no single CT
Event Ratesis
Annualized Event Rates
CT Positive CT Negative
e No. of
Events (%)
Annualized
Event Rate
Prevalence
(%)
No. of
Events (%)
Annualized
Event Rate
%) 20 (62.5%) 57.7% 68 (68.0%) 6 (8.8%) 8.1%
%) 56 (58.9%) 50.5% 125 (56.8%) 3 (2.4%) 2.1%
%) 16 (29.1%) 12.7% 172 (75.8%) 2 (1.2%) 0.5%
%) 20 (21.5%) 6.5% 400 (81.1%) 1 (0.3%) 0.09%
%) 17 (4.9%) 3.3% 802 (69.7%) 4 (0.5%) 0.33%
%) 17 (48.6%) 24.3% 152 (81.3%) 3 (2.0%) 1.0%
%) 48 (22.0%) 14.5% 327 (60.0%) 5 (1.5%) 0.99%
%) 10 (11.2%) 6.0% 227 (71.8%) 7 (3.1%) 1.7%
%) 12 (11.0%) 6.5% 323 (74.8%) 14 (4.3%) 2.5%
11.9% 70.7% 1.1%
) 26 (32.5%) 30.0% 20 (20%) 0 (0%) 0%
%) 59 (33%) 28.3% 43 (19.5%) 0 (0%) 0%
%) 68 (4.7%) 0.72% 1,085 (42.7%) 18 (1.7%) 0.26%
%) 15 (6.5%) 3.5% 85% (26.9%) 1 (1.2%) 0.64%
%) 24 (8.4%) 4.9% 133 (39.8%) 3 (2.3%) 1.35%
4.0% 37.8% 0.4%
art of the table) and any atherosclerotic plaque (bottom part of the table), number of events (%),
nd in subjects with CT positive and CT negative findings (presence and absence of CT angiographic
eighted by sample size. One study (Min, 2007 [13]) was excluded from the table because events
2) and the European Heart Journal (24).izedtenos
, and
valenc
(%)
2 (32.0
5 (43.2
5 (24.2
3 (18.9
8 (30.3
5 (18.7
8 (40.0
9 (28.2
9 (25.2
9.3%
0 (80%
7 (80.5
3 (57.3
1 (73.1
9 (69.2
2.3%
s (top p
point) apredictor of interest uniformly reported across all 11 studies
rvention
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ing of available outcome data. Our study demonstrates that
the following CT findings are associated with worse out-
comes and thus should be included as standard reporting
elements in clinical reports as well as in future research
studies: 1) the presence of at least 1 coronary artery stenosis
exceeding 50% diameter stenosis per patient; 2) the
number of coronary segments containing at least 1 coronary
artery stenosis exceeding 50% diameter; 3) left main
coronary artery disease; 4) the presence of any detectable
atherosclerotic plaque (regardless of severity) per patient;
and 5) the number of segments containing any nonobstruc-
tive plaque, calcified, noncalcified, and mixed plaque (non-
calcified and calcified plaque components).
Another major difference across studies was related to the
choice of outcomes. Forty percent of studies (data not shown)
reported on multiple events per subject with subjects reaching
soft and hard endpoints subsequently (i.e., unstable angina
followed by revascularization procedure). Although in each
study the relative risks were adequately derived, further pooled
Random Effect Meta-Analysis of Relationship BeCoronary Plaque and Stenosis Risk of CombinedAccording to Pote tial Sources of He er geneit
Table 4
Random Eff ct Meta-An lysi of Re
Coronary Plaque and Stenosis Risk
According to Potential Sources of H
Variable Studies Events/Parti
Average age, yrs
58* 4 126/1,6
58 5 126/2,0
Proportion of males
65%* 5 180/2,5
65% 4 72/1,1
Obesity (BMI 30 kg/m2)
22.6%* 2 77/447
22.6% 4 75/2,0
History of CAD
Any history 2 85/320
None 7 167/3,3
CT technology
64-slice CT 7 205/3,0
16-slice/EBCT 2 47/597
Follow-up time, months
22.3* 4 80/1,3
22.3 3 172/2,3
Revasc. in endpoint
Revasc. not included 3 55/1,2
Revasc. included 6 197/2,4
Adjusted analysis
Adjusted 7 213/2,5
Unadjusted 1 21/1,1
Study quality
Higher 5 106/2,1
Lower 4 146/1,5
Potential model overfitting
No 3 133/1,9
Yes 6 119/1,7
*Stratified by median.
Revasc.  revascularization defined as percutaneous coronary inteanalysis on hard and soft endpoints was unattainable.We detected higher risk associated with CT findings in
studies including revascularization compared to studies
without CT findings. That is particularly relevant as 62% of
all endpoints were revascularizations, and whereas the an-
nualized overall event rate was 5% across all studies, it
dropped significantly to 1% for death, nonfatal MI, and
unstable angina requiring hospitalization. Because coronary
revascularization in this context is a management option
without any proven effect of health outcomes, it should be
reported in conjunction with test utilization and efficiency of
cardiac CTA rather than efficacy and effectiveness. As
virtually all CT results were unblinded, differences in
outcomes and strength of associations may therefore also be
an expression of the substantial work-up bias/confounding
by indication. However, although a number of studies
excluded revascularizations within 30 days after CT imag-
ing, its choice as an endpoint in prognostic studies remains
questionable. It appears that classical endpoints such as
death, MI, and unstable angina requiring revascularization
should be used for imaging studies as well. Therefore, it is
n CT Angiographic Finding ondiovascular Event Stratifiedship Between CT Angiographic Finding on
mbined Cardiovascular Event Stratified
ogeneity
s Hazard Ratio (95% CI) p Value for Difference
19.83 (10.04–39.16) 0.02
7.17 (4.23–12.15)
15.25 (7.23–32.21) 0.21
8.04 (4.13–15.67)
12.75 (4.51–36.12) 0.43
7.07 (2.5–19.95)
17.27 (3.81–78.27) 0.51
10.06 (5.66–17.87)
9.63 (5.42–25.07) 0.34
19.56 (5.10–75.01)
11.65 (5.42–25.07) 0.72
14.39 (5.86–35.37)
6.15 (3.22–11.74) 0.03
15.41 (8.92–26.62)
8.18 (4.79–13.99) 0.28
16.1 (5.28–49.10)
16.83 (10.08–28.11) 0.001
5.86 (3.34–10.29)
13.27 (5.41–32.57) 0.57
9.58 (4.88–18.80)
or bypass; other abbreviations as in Tables 1 and 2.tweeCarylation
of Co
eter
cipant
57
13
08
62
85
50
77
39
31
41
29
20
50
57
13
15
55clear that a prospective study focusing on clinically more
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these event rates are very low. An example is the ongoing
10,000-patient PROMISE (PROspective Multicenter Im-
aging Study for the Evaluation of Chest Pain) trial, which
compares hard endpoints for functional versus anatomic
testing in patients with suspected CAD.
The importance of exact outcome and population
definitions is further supported by substantial variability
Figure 3 Risk Estimates for the Presence of Left Main Stenosi
(A) Presence of left main coronary artery stenosis. (B) Each significant coronary a
“Adjusted” indicates whether multivariate adjustment was performed. Horizontal lines
and the size of the rectangle is proportional to the weight given to each study in the
CI). The dashed vertical line represents the reference of no increased risk. Figure byof the annualized event rates and prevalence of CTfindings among subjects with and without significant
coronary stenosis (3 up to 58% annualized event rate),
which was clearly dependent on whether revasculariza-
tion was included in the endpoint or not (annualized
event rate 11.9% vs. 6.4% for studies including vs.
excluding revascularization, respectively). Also, partially,
the variability may be attributable to population differ-
ence and differences in clinical setting as the prevalence
r Significant Stenosis, and 3-Vessel Disease
tenosis (maximum of 17). (C) Presence of 3-vessel obstructive disease.
ent 95% confidence intervals (CIs). The rectangles represent the point estimate,
nalysis. The diamond represents the summary estimate (size of the diamond  95%
kaggs. HR  hazard ratio.s, pe
rtery s
repres
meta-a
Craig Sof CT findings was similarly heterogeneous (18% up to
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identified age as a major source.
Our results further indicate that coronary CTA may
provide incremental prognostic information beyond the
analysis of coronary calcium. However, this finding is only
Figure 4 Risk Estimates for the Presence of Plaque, per Segm
(A) Any atherosclerotic plaque within the coronary artery tree. (B) Each coronary s
ment containing noncalcified atherosclerotic plaque. As derived by the reciprocal.
nal (24). Adjusted indicates whether multivariate adjustment was performed. Hor
point estimate, and the size of the rectangle is proportional to the weight given to
of the diamond  95% CI). The dashed vertical line represents the reference of n
ratio; N/A  not applicable.based on 3 studies and will thus need to be confirmed inlarger, dedicated analyses. That is specifically relevant as the
incremental value of CAC beyond established risk factors is
well known (2), and coronary calcium scores are easily
obtainable whereas coronary CTA requires more sophisti-
cated equipment, injection of contrast, and higher radiation
f Any Plaque, per Segment of Noncalcified Plaque
t containing any atherosclerotic plaque (maximum of 17). (C) Each coronary seg-
09, the same lead author published in Heart (12) and the European Heart Jour-
l lines represent 95% confidence intervals (CIs). The rectangles represent the
study in the meta-analysis. The diamond represents the summary estimate (size
ased risk. Figure by Craig Skaggs. CT  computed tomography; HR  hazardent o
egmen
†In 20
izonta
each
o increexposure. Interestingly, in a large meta-analysis on the
e
A
d
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investigators derive a 10-fold pooled estimate associated
with an Agatston score 400, similar to our derived
stimates for the presence of significant coronary stenosis.
n interesting objective for future research will be to
etermine whether an Agatston score 400 is associated
with a similar risk as the presence of significant coronary
stenosis.
We also present initial summary risk estimates for the
presence and extent of exclusively noncalcified plaque,
which may be 1 of the potential benefits of cardiac CTA as
it represents up to 80% of the total atherosclerotic plaque
burden (27), and on a case basis is considered to be
associated with acute coronary syndrome (28). Our results
indicate that the extent of noncalcified plaque was associ-
ated with a slightly higher risk as any atherosclerotic plaque
(HR: 1.29 vs. 1.23, respectively); however, we did not have
the statistical power to detect true difference between the 2
entities of atherosclerotic plaque as the finding was based on
3 smaller studies only (11,20,24). Thus, further research is
necessary to elucidate the incremental value of noncalcified
plaque beyond the calcified plaque component.
Study limitations. Notably, our results were derived from
cohorts enrolling symptomatic subjects, and all subjects
underwent cardiac CTA for clinically suspected CAD.
Thus, our results do exclusively apply to these symptomatic
patients and cannot be generalized to an asymptomatic
population. That is in line with recommendations from
clinical practice guidelines (2), which recommend cardiac
CTA in the diagnostic setting by ruling out significant
coronary artery disease in low-risk to intermediate-risk
populations. Nevertheless, in these subjects, the prognostic
information pertaining to distinct CT findings is available at
no extra cost and can potentially help to improve risk
assessment. Potentially, further advances in technology to
reduce radiation exposure, including prospective triggering
and high-pitch protocols, will make scanning of asymptom-
atic subjects for risk stratification more amenable.
We were not able to analyze the incremental predictive
value of CT findings on plaque and stenosis beyond other
markers of cardiovascular risk as only 1 study assessed the
prognostic value over single-positron emission CT myocar-
dial perfusion imaging (6). In this study, Van Werkhoven et
al. (6) found a synergistic role of both modalities covering
anatomical and functional information for risk stratification.
Clearly, upcoming studies should focus on the incremental
value of cardiac CT in comparison with other imaging
techniques, such as single-positron emission CT and echo-
cardiography as well as serum biomarkers or clinical predic-
tion rules of increased risk.
Importantly, a general limitation of this analytic tech-
nique is that the validity of the results depends on each
single original study. Also, our meta-analytic approach
relied on combining the aggregate HR and associated 95%
CI from each trial using random-effect modeling accounting
for heterogeneity among the original studies. Also, thenumber of potential confounders we investigated in meta-
regression was high, with the risk of false positive findings.
Given the nature of published reports, we were unable to
combine individual patient outcome data of each study,
which may have provided more insight into particular
subgroups of patients. (Fig. 3)
Conclusions
In this meta-analysis, we identify a set of coronary CTA
findings based on the presence and extent of CAD that are
strong predictors of cardiovascular events in symptomatic
subjects clinically referred for cardiac CT, independent of
coronary artery calcification and cardiovascular risk factors.
We also demonstrate that choice of endpoints, classification
of CT findings, and study population (age) introduced
substantial heterogeneity with respect to risk prediction
among existing studies.
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